America in Transition Pages

Tuesday, December 8, 2015

FDA OK's Genetically Engineered Drug for Bleeding Disorder

(MedPage Today) -- Vonvendi is first recombinant von Willebrand factor replacement product

from MedPage Today Washington Watch http://ift.tt/1NgQsH0
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)